News
Mumbai: Haffkine Bio-Pharmaceuticals procurement cell will be seeking explanations from two pharmaceutical firms after it came to light that medicines.
Vildagliptin was generally shown to have a beneficial or neutral effect on lipid parameters; however, one study reported a small decrease in HDL cholesterol levels, ...
If vildagliptin is approved for marketing, it will add to the available treatment options for diabetes and will provide patients and health care providers with another noninjectable therapy option.
Akums unveils Vildagliptin SR, Metformin SR tablets combination for type 2 diabetes - ET HealthWorld
Vildagliptin, a well-tolerated oral dipeptidyl peptidase-4 inhibitor, stands out for its unique mechanism of action that prevents the degradation of glucagon-like peptide-1 (GLP-1).
Galvus MET (50+500) 50mg/500mg - 15 Tablets (Vildagliptin - Combination of Generics) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects ...
Glenmark has become the first company to launch Remogliflozin + Vildagliptin + Metformin fixed-dose combination (FDC) drug at an affordable price for adults with Type 2 Diabetes.
Vildagliptin is an antihyperglycemic medication that inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme selectively. It is used to treat type 2 diabetes mellitus, which is characterized by impaired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results